Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIFIFI
NCT02823886Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoints: Relationship between interleukin-1beta serum level and infarct size at Day 7, Relationship between interleukin 6 serum level and infarct size at Day 7 and 5 more. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT02823886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823886.